Automated in Vitro Screening of Teratogens
- 15 May 2002
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 181 (1), 1-15
- https://doi.org/10.1006/taap.2002.9393
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Thalidomide‐Induced Antigen‐Specific Immune Stimulation in Patients with Human Immunodeficiency Virus Type 1 and TuberculosisThe Journal of Infectious Diseases, 2000
- Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centreEuropean Journal of Pharmacology, 1998
- Inhibition of Angiogenesis by Thalidomide Requires Metabolic Activation, Which Is Species-dependentBiochemical Pharmacology, 1998
- Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase Cα expression and activityJournal of Cellular Physiology, 1997
- Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitroToxicology in Vitro, 1996
- Further Branching of Valproate-Related Carboxylic Acids Reduces the Teratogenic Activity, but Not the Anticonvulsant EffectChemical Research in Toxicology, 1996
- Neural crest cell formation and migration in the developing embryoThe FASEB Journal, 1994
- Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents.Proceedings of the National Academy of Sciences, 1982
- Thalidomide metabolite inhibits tumor cell attachment to concanavalin A coated surfacesBiochemical and Biophysical Research Communications, 1981
- Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfacesNature, 1979